The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
Open accessAbstract
Purpose: To compare the effectiveness of mammography, breast ultrasound, and magnetic resonance imaging (MRI) for surveillance of women at increased familial risk for breast cancer (lifetime risk of 20% or more). Patients and Methods: We conducted a surveillance cohort study of 529 asymptomatic women who, based on their family history and/or mutational analysis, were suspected or proven to carry a breast cancer susceptibility gene (BRCA). A total of 1,542 annual surveillance rounds were completed with a mean follow-up of 5.3 years. Diagnostic accuracies of the three imaging modalities used alone or in different combinations were compared. Results: Forty-three breast cancers were identified in the total cohort (34 invasive, nine ductal carcinoma-in-situ). Overall sensitivity of diagnostic imaging was 93% (40 of 43 breast cancers); overall node-positive rate was 16%, and one interval cancer occurred (one of 43 cancers, or 2%). In the analysis by modality, sensitivity was low for mammography (33%) and ultrasound (40%) or the combination of both (49%). MRI offered a significantly higher sensitivity (91%). The sensitivity of mammography in the higher risk groups was 25%, compared with 100% for MRI. Specificity of MRI (97.2%) was equivalent to that of mammography (96.8%). Conclusion: Mammography alone, and also mammography combined with breast ultrasound, seems insufficient for early diagnosis of breast cancer in women who are at increased familial risk with or without documented BRCA mutation. If MRI is used for surveillance, diagnosis of intraductal and invasive familial or hereditary cancer is achieved with a significantly higher sensitivity and at a more favorable stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,423
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171 · cited 1×
“BRCA2 mutations compared with so-called watchful waiting.(13-16) Nonetheless, the perceived mutilating effects of mastectomy make the decision for surgical prevention difficult, and current national guidelines do not recommend it as standard management.”
BackgroundBreast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973 · cited 1×
“BRCA2 mutations compared with so-called watchful waiting.(13-16) Nonetheless, the perceived mutilating effects of mastectomy make the decision for surgical prevention difficult, and current national guidelines do not recommend it as standard management.”
BackgroundBurke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Breast Carcinoma: Effect of Preoperative Contrast-enhanced MR Imaging on the Therapeutic Approach
Fischer, U., Kopka, L., & Grabbe, E. (1999) · Radiology · doi:10.1148/radiology.213.3.r99dc01881 · Cited by 664
Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Metcalfe, K., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., Olopade, O. I., Eisen, A., Weber, B., McLennan, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.033 · Cited by 621
Stratton, M. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10109-4 · Cited by 579
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Self-citationKolb, T. M., Lichy, J., & Newhouse, J. H. (1998) · Radiology · doi:10.1148/radiology.207.1.9530316 · Cited by 472
Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
Positive Predictive Value of Screening Mammography by Age and Family History of Breast Cancer
Kerlikowske, K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510200050031 · Cited by 364
Brekelmans, C. T. M., Seynaeve, C., Bartels, C. C. M., Tilanus-Linthorst, M. M. A., Meijers-Heijboer, E. J., Crepin, C. M. G., van Geel, A. N., Menke, M., Verhoog, L. C., van den Ouweland, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.924 · Cited by 307
Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians
Hoskins, K. F. (1995) · JAMA · doi:10.1001/jama.1995.03520310075033 · Cited by 294
Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Stoutjesdijk, M. J., Boetes, C., Jager, G. J., Beex, L., Bult, P., Hendriks, J. H. C. L., Laheij, R. J. F., Massuger, L., van Die, L. E., Wobbes, T., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1095 · Cited by 289
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Goffin, J., Chappuis, P. O., Wong, N., & Foulkes, W. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1754 · Cited by 284
Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. S., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Venter, D. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n · Cited by 259
Lazovich, D., Solomon, C. C., Thomas, D. B., Moe, R. E., & White, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990815)86:4<628::aid-cncr11>3.0.co;2-l · Cited by 254
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., Ellis, N., Hensley, M., Boyd, J., Borgen, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1260 · Cited by 239
German Consortium for Hereditary Breast and Ovarian Cancer (2002) · International Journal of Cancer · doi:10.1002/ijc.1626 · Cited by 205
Tilanus‐Linthorst, M., Verhoog, L., Obdeijn, I., Bartels, K., Menke‐Pluymers, M., Eggermont, A., Klijn, J., Meijers‐Heijboer, H., van der Kwast, T., & Brekelmans, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10666 · Cited by 195
Andrés Conejero, R., Lastra del Prado, R., Zurera Berjaga, M., & Arévalo Vázquez, E. (2022) · Revisiones en Cáncer · doi:10.20960/revcancer.00003 · Cited by 193
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks
Zhong, Q., Chen, C., Chen, P., & Lee, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200748200 · Cited by 176
The development of interval breast malignancies in patients with BRCA mutations
Komenaka, I. K., Ditkoff, B., Joseph, K.-A. P., Russo, D., Gorroochurn, P., Ward, M., Horowitz, E., El-Tamer, M. B., & Schnabel, F. R. (2004) · Cancer · doi:10.1002/cncr.20221 · Cited by 155
Vasen, H. F. A., Haites, N. E., Evans, D. G., Steel, C. M., Møller, P., Hodgson, S. V., Eccles, D., Morrison, P. J., Stoppa‐Lyonnet, D., Chang-Claude, J. C., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00288-3 · Cited by 106
Foulkes, W. D., Metcalfe, K. A., Hanna, W. M., Lynch, H. T., Ghadirian, P., Tung, N., Olopade, O. I., Weber, B., McLennan, J., Olivotto, I. A., et al. (2003) · Cancer · doi:10.1002/cncr.11688 · Cited by 103
Somasundaram, K. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10469 · Cited by 87
Evidence-based management options for women at increased breast/ovarian cancer risk
Pichert, G., Bolliger, B., Buser, K., & Pagani, O. (2002) · Annals of Oncology · doi:10.1093/annonc/mdg030 · Cited by 64
Prophylactic bilateral mastectomy
Metcalfe, K., Goel, V., Lickley, L., Semple, J., & Narod, S. (2002) · Cancer · doi:10.1002/cncr.10680 · Cited by 23
Cited by
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Metadata
- Authors
- Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-11-20
- Volume
- 23
- Issue
- 33
- Pages
- 8469-8476
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2115947304
- Cited by
- 1,147
- References
- 34
- FWCI
- 35.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.